Email Newsletters

Life Sciences

Masy BioServices opens office in North Carolina

Pepperell-based Masy BioServices, a biorepository company, is continuing its expansion on the eastern seaboard by opening an office in North Carolina's Research Triangle Park.

Cogmedix to expand with new West Boylston HQ

Worcester medical device contract manufacturer Cogmedix is expanding its facilities and moving into a new headquarters at an 80,000-square-foot building in West Boylston.

Boston Scientific to acquire Calif. biotech for $465M

Marlborough medical device giant Boston Scientific will acquire a California biotech company specializing in treating lumbar spinal stenosis for at least $465 million.

Harvard Bioscience reduces 2019 guidance due to global trade issues

Holliston lab equipment manufacturer Harvard Bioscience is expecting a weaker 2019 after a slow start to the year, which saw weaker demand from customers in Europe.
ADVERTISEMENT

Mustang Bio stock soars on licensing deal for ‘bubble boy disease’

Mustang Bio, which operates a biomanufacturing facility in Worcester, saw its market cap nearly triple after it announced a licensing agreement with St. Jude Children's Research Hospital.

Miach Orthopaedics adds two executives ahead of FDA submissions

Westborough biotech Miach Orthopaedics has added two senior executives with expertise in regulatory submissions and clinical trials as the company looks to bring its ACL repair technology to market.

Cummings School names Canadian veterinary school founder as dean

The Cummings School of Veterinary Medicine at Tufts University in North Grafton has named the founding dean of the University of Calgary veterinary program as its new dean.

Mustang Bio gets $20M venture debt financing for Worcester facility

New York-based biotech Mustang Bio has secured $20 million to develop gene and cell therapies at its Worcester facility, it announced Monday.
ADVERTISEMENT

Three biotech firms plan moves following tax break approval

Olympus is planning to relocate Southborough and Littleton workers in Westborough, and two others are planning new facilities in Hopkinton and Marlborough.

Synspira Therapeutics names new CEO

Framingham clinical-stage biopharma Synspira Therapeutics has named a new CEO with experience in leading biotech companies from startup stage to market.
ADVERTISEMENT

Latest Stories

More Business News
ADVERTISEMENT

Thought Leadership

More Thought Leadership

Career Opportunities

More Jobs | Submit a Job
More Events | Submit an Event

Get our email newsletter

Stay up-to-date on the companies, people and issues that impact businesses in Central Massachusetts.

Close the CTA